Procurement Summary
Country : Switzerland
Summary : Global Fund-s 6th Replenishment Campaign
Deadline : 07 Sep 2018
Other Information
Notice Type : Tender
TOT Ref.No.: 25788753
Document Ref. No. : TGF-18-070
Competition : ICB
Financier : Global Fund to Fight AIDS, Tuberculosis and Malaria (GFFATM)
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA
The Global Fund to Fight AIDS, Tuberculosis and Malaria Global Health Campus Chemin du Pommier 40 1218 Grand-Saconnex Geneva
Tel: +41-587911700
Fax: +41-445806820
Switzerland
Email :manon.vanrijswijk@theglobalfund.org/amber.meixner@theglobalfund.org
Tender Details
Request for proposals are invited for Global Fund-s 6th Replenishment Campaign.
Smart, effective health investments through the Global Fund have saved 27 million lives. Through
collective global commitment, we have proven that when the world comes together we can achieve
remarkable success against the world-s most deadly infectious diseases.
(Risks Today - HIV/TB/Malaria)
While incredible progress has been made in global health, these gains are under threat unless we
commit more funding and continue to evolve and innovate our response to fighting the epidemics.
Business as usual will not end AIDS, TB and malaria.
(HIV: Risk today, and how the Global Fund is tackling it)
We are not on track to end the HIV epidemic by 2030. Despite amazing progress - cutting AIDS
deaths in half over the past decade - we now face alarming new challenges and risks, which are
further fueled by a dangerous rising complacency in the fight against HIV. Infection rates are
increasing among key populations — sex workers, LGBTI, prisoners, migrant populations, people
who inject drugs — those left behind by society. The disease also preys on adolescent girls and
young women, and if current trends continue we could have more infections by 2030 in subSaharan
Africa than when the disease was at its peak in the 2000s.
In response, the Global Fund is adapting our approach to support countries to develop new
models of differentiated care. The goal: to ensure that the right services, each tailored to the needs
of different populations and communities in the highest burden countries, are in place to fight
HIV where it is most destructive. With increased resources and renewed energy, we can leverage
the right tools and achieve dramatic impact through effective prevention and treatment.
(Tuberculosis: Risk today, and how the Global Fund is tackling it)
Tuberculosis is now the leading cause of death from infectious disease, resulting in 1.7 million
deaths per year. Largely eradicated in industrialized nations by antibiotics, in the developing
world there are an estimated 10.4 million new cases of TB every year. The rate of decline in TB is
slow due to an estimated 4.1 million people with tuberculosis being missed every year who
contribute to further transmission of the disease. One person with active, untreated TB can spread
the disease to as many as 15 other people in a year. This alarming trend is further exacerbated by
antimicrobial resistance, one of the most significant threats to global health security today.
Stopping TB requires a focused approach to finding missing cases, renewed resources and highlevel
political commitment to prioritize TB as a public health issue. By investing heavily in the
expansion of improved diagnostic technology, which detects TB faster and with greater accuracy,
detecting drug resistance within just hours, we can achieve tremendous impact against the
disease. New solutions to fight antimicrobial resistance are also critical. As the leading funder of
the TB response globally, the Global Fund has the ability to drive innovation and renewed
commitment to tackle TB.
Documents
Tender Notice